PURE Bioscience To Present At The Aegis Healthcare Conference On September 28
PURE Bioscience, Inc. (NASDAQ: PURE ), the creator of the patented silver dihydrogen citrate (SDC) antimicrobial, announced that Chief Executive Officer Michael L. Krall is schedule to present at the Aegis Capital Healthcare Conference on Friday, September 28, 2012 at 8:00 a.m. Pacific. The conference is being held at The Wynn in Las Vegas.
About Aegis Capital
Founded in 1984, Aegis Capital Corp. is a full service retail and institutional broker-dealer located in New York City. Aegis Capital’s management is committed to providing the highest level of service to its clients. The firm realizes this goal by running an independent, conflict-free platform that is focused on enhancing the goals of our clients by bringing unencumbered advice, which enables them to freely create a plan centered on each client. Aegis Capital continues to meet the challenging and changing markets by investing in world-class services such as access to independent research for its financial advisors and their clients from JP Morgan, Bloomberg, Moody’s, Lipper, Best Independent Research LLC, and Argus Research. Aegis Capital’s clients have access to Asset Management Services with world-class managers.
About PURE Bioscience, Inc.PURE Bioscience, Inc. develops and markets technology-based bioscience products that provide solutions to numerous global health challenges, including Staph (MRSA). PURE’s proprietary high efficacy/low toxicity bioscience technologies, including its silver dihydrogen citrate-based antimicrobials, represent innovative advances in diverse markets and lead today’s global trend toward industry and consumer use of “green” products while providing competitive advantages in efficacy and safety. Patented SDC is an electrolytically generated source of stabilized ionic silver, which formulates well with other compounds. As a platform technology, SDC is distinguished from competitors in the marketplace because of its superior efficacy, reduced toxicity and the inability of bacteria to form a resistance to it. PURE is headquartered in El Cajon, California (San Diego metropolitan area). Additional information on PURE is available at www.purebio.com.
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV